SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation



White, Katie D, Abe, Riichiro, Ardern-Jones, Michael, Beachkofsky, Thomas, Bouchard, Charles, Carleton, Bruce, Chodosh, James, Cibotti, Ricardo, Davis, Robert, Denny, Joshua C
et al (show 34 more authors) (2018) SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 6 (1). pp. 38-69.

[thumbnail of SJS-TEN Research Directions Text Clean resubmitted.082817.docx] Text
SJS-TEN Research Directions Text Clean resubmitted.082817.docx - Author Accepted Manuscript

Download (56kB)
[thumbnail of SJS-TEN Research Directions Table 1 resubmitted.082817.docx] Text
SJS-TEN Research Directions Table 1 resubmitted.082817.docx - Author Accepted Manuscript

Download (18kB)
[thumbnail of Suppl Table 1.HighRiskDrugsAlleles resubmitted.082817.docx] Text
Suppl Table 1.HighRiskDrugsAlleles resubmitted.082817.docx - Author Accepted Manuscript

Download (13kB)

Abstract

Stevens-Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) is a life-threatening, immunologically mediated, and usually drug-induced disease with a high burden to individuals, their families, and society with an annual incidence of 1 to 5 per 1,000,000. To effect significant reduction in short- and long-term morbidity and mortality, and advance clinical care and research, coordination of multiple medical, surgical, behavioral, and basic scientific disciplines is required. On March 2, 2017, an investigator-driven meeting was held immediately before the American Academy of Dermatology Annual meeting for the central purpose of assembling, for the first time in the United States, clinicians and scientists from multiple disciplines involved in SJS/TEN clinical care and basic science research. As a product of this meeting, this article summarizes the current state of knowledge and expert opinion related to SJS/TEN covering a broad spectrum of topics including epidemiology and pharmacogenomic networks; clinical management and complications; special populations such as pediatrics, the elderly, and pregnant women; regulatory issues and the electronic health record; new agents that cause SJS/TEN; pharmacogenomics and immunopathogenesis; and the patient perspective. Goals include the maintenance of a durable and productive multidisciplinary network that will significantly further scientific progress and translation into prevention, early diagnosis, and management of SJS/TEN.

Item Type: Article
Uncontrolled Keywords: Stevens-Johnson, Toxic epidermal necrolysis, HLA, Networks, Pharmacogenomics, Pharmacovigilance, Electronic health record, T cells, Granulysin
Depositing User: Symplectic Admin
Date Deposited: 27 Mar 2018 14:03
Last Modified: 19 Jan 2023 06:37
DOI: 10.1016/j.jaip.2017.11.023
Related URLs:
URI: https://livrepository.liverpool.ac.uk/id/eprint/3019528